In the latest development in a long-simmering debate, the FDA has announced that aspirin should not be marketed for the prevention of a first heart attack or stroke in people with no history of ... more 
In the latest development in a long-simmering debate, the FDA has announced that aspirin should not be marketed for the prevention of a first heart attack or stroke in people with no history of cardiovascular disease. The announcement follows FDA’s rejection on Friday of Bayer Healthcare’s decade-old petition requesting approval of a primary prevention indication. Aspirin is still widely used for primary prevention. The American Heart Association currently supports the use of aspirin for primary prevention when recommended by a physician in high risk patients. less 
1 / 27
Wochit
Mon, May 5, 2014 2:51 PM EDT